Search
Bevacizumab
There is a great deal of evidence indicating that vascular endothelial growth factor (VEGF) is important for the survival and proliferation of cancer cells. VEGF plays an important role in angiogenesis, lymphangiogenesis, and tumor growth, which are all factors that contribute to its attractiveness as a therapeutic ...
Bevacizumab zirconium Zr-89
go.drugbank.com/drugs/DB14907InvestigationalBevacizumab zirconium Zr-89 is under investigation in clinical trial NCT01338090 (89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors).
Synonyms: 89ZR-BEVACIZUMAB, Bevacizumab zirconium Zr-89Bevacizumab Action Pathway
smpdb.ca/view/SMP0000420Drug actionBevacizumab is a humanized anti-VEGF monoclonal antibody used in the treatment of cancer. … Bevacizumab exerts its effect by binding to extracellular VEGF and preventing its binding to receptors on the endothelial cell surfaces.
Drugs: BevacizumabEnzymes: BevacizumabBevacizumab VEGF Inhibitor Action Pathway
smpdb.ca/view/SMP0122788Drug actionBevacizumab is a humanized monoclonal antibody administered intravenously to treat cancers such as colorectal cancer; non-small cell lung cancer; glioblastoma; hepatocellular cancer; renal cell carcinoma … Bevacizumab binds to VEGF in the blood and inactivates it, preventing its interaction with the VEGF receptors. The VEGF signaling pathway is not activated and angiogenesis does not occur.
Drugs: BevacizumabVEGF Signaling
smpdb.ca/view/SMP0524112SignalingInhibitors like Bevacizumab and Aflibercept block VEGF A, preventing its effects and inhibiting angiogenesis, making them useful in treating cancers and other diseases with abnormal blood vessel growth
Enzymes: BevacizumabRecurrent platinum-sensitive fallopian tube cancer
go.drugbank.com/conditions/DBCOND0128089Drugs: Bevacizumab